The digital twin paradox: why precision medicine needs more than data

Digital twins, which are virtual replicas of a patient, are often sold as a shortcut to personalized medicine. But the real value of this technology is not that it provides instant answers. Instead, it forces a necessary pause in clinical decision-making. By moving from reactive treatment to predictive simulation, we can test interventions in a safe digital space. However, this creates a shift in the doctor-patient relationship and introduces new systemic risks. For clinicians and health-tech leaders, the goal is to master the human-machine interface. This means learning how to use algorithmic insights without losing the human judgment required to prevent clinical errors.

Moving from static models to dynamic journeys

Most medical data is a snapshot. A blood test or an imaging scan captures a single moment, providing a static view of a complex system. Dr. Caroline Chung, a radiation oncologist at MD Anderson, distinguishes true digital twins from these snapshots. She compares them to aerospace engineering, where digital replicas allow engineers to stress-test aircraft parts without risking a flight failure. Chung notes that a medical digital twin must be an ongoing interaction.

It is not just a model. It is a system that updates as new data arrives. This creates a feedback loop that lets clinicians simulate the effects of different treatment schedules before they administer a dose of chemotherapy.

A digital twin is more than just the model that can actually predict what is going to happen to you; it really is an ongoing interaction between what the model will predict your actions based on what information you receive and continued data collection to update the information and predictions using that model.

-- Dr. Caroline Chung

Why fit for purpose beats the virtual human

There is a temptation to build a virtual human, which would be a complete digital replica of every body system. Systems thinking suggests this is a mistake. Expanding the scope of a model increases the chance of failure and creates serious privacy risks. Because a comprehensive digital twin would be uniquely identifiable, the more data you collect, the more vulnerable the patient becomes.

Chung argues for a fit for purpose approach. By focusing on specific clinical questions, such as optimizing radiation dosage for a specific tumor, clinicians can build robust models that rely on known physical laws rather than AI-generated errors. This disciplined approach avoids the complexity of building a universal model that is too difficult to manage and too sensitive to secure.

The hidden cost of speed in clinical decisions

The most dangerous byproduct of the AI era is the demand for speed. We want faster answers, so we build tools that provide them. But as Chung points out, the pause is the most critical part of medical discernment.

I think that one of the pieces that has come amidst the whole AI era is everyone wants things faster... and then because speed and acceleration is perhaps an innate goal with this technology or what's been marketed to us as the goal there is less pause that happens and the pause is probably the critical piece that will allow us to be discerning.

-- Dr. Caroline Chung

When an algorithm provides a recommendation, it triggers a cognitive bias: the assumption that the machine is right. If clinicians stop questioning the output, they lose the ability to catch errors or account for the personal social factors that an algorithm cannot see. The advantage for the next generation of practitioners will not be in faster processing, but in the design of interfaces that force critical reflection.

Key action items

• Audit data pipelines for continuity (Immediate): Evaluate whether your current health data collection is a series of snapshots or a continuous stream. Digital twins require the latter; invest in infrastructure that supports longitudinal data flow.
• Adopt mechanistic constraints (Next 6 months): When evaluating AI tools, prioritize models that incorporate physics-informed or mechanistic constraints. Avoid black box models that lack the guardrails necessary to prevent inaccurate predictions.
• Design for the clinical pause (Next 6-12 months): If you are building or implementing clinical software, design the user interface to force a pause before a decision is finalized. This creates the cognitive space required for human-AI collaboration.
• Shift from total integration to fit for purpose (12-18 months): Resist the urge to build monolithic models. Instead, map out specific, high-value clinical problems and build targeted digital twins that solve for those specific variables.
• Develop privacy-first governance (12-18 months): Because digital twins are inherently identifiable, establish clear ownership and access protocols now. Waiting until the technology is mainstream will likely lead to regulatory bottlenecks that could stall adoption.